| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Chief Operating Officer | Stock Option (Right to Buy) | 0 | $951,720 | $36.05 | 17 Jul 2025 | Direct |
| Blueprint Medicines Corp | Chief Operating Officer | Common Stock | 0 | $0 | $101.84 | 17 Jul 2025 | Direct |
| Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 31,000 | 11 Jun 2025 | Direct | ||
| CG Oncology, Inc. | Director | Director Stock Option (right to buy) | 20,889 | 24 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 24 Nov 2025 | 1 | $0 | 4 | Director | 26 Nov 2025, 16:30 |
| CGON | CG Oncology, Inc. | 24 Nov 2025 | 0 | $0 | 3 | Director | 26 Nov 2025, 16:15 |
| BPMC | Blueprint Medicines Corp | 17 Jul 2025 | 11 | $0 | 4 | Chief Operating Officer | 21 Jul 2025, 19:47 |
| BPMC | Blueprint Medicines Corp | 03 Jul 2025 | 1 | -$150,309 | 4 | CHIEF OPERATING OFFICER | 08 Jul 2025, 16:20 |
| XLO | Xilio Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 16:34 |
| BPMC | Blueprint Medicines Corp | 19 May 2025 | 3 | -$228,557 | 4 | CHIEF OPERATING OFFICER | 21 May 2025, 16:33 |
| BPMC | Blueprint Medicines Corp | 05 May 2025 | 4 | -$231,386 | 4 | CHIEF OPERATING OFFICER | 07 May 2025, 16:32 |
| BPMC | Blueprint Medicines Corp | 24 Mar 2025 | 1 | -$216,075 | 4 | CHIEF OPERATING OFFICER | 26 Mar 2025, 16:27 |
| BPMC | Blueprint Medicines Corp | 05 Mar 2025 | 1 | -$576,756 | 4 | CHIEF OPERATING OFFICER | 07 Mar 2025, 16:14 |
| BPMC | Blueprint Medicines Corp | 01 Mar 2025 | 2 | $0 | 4 | CHIEF OPERATING OFFICER | 04 Mar 2025, 17:18 |
| BPMC | Blueprint Medicines Corp | 20 Feb 2025 | 1 | -$216,348 | 4 | CHIEF OPERATING OFFICER | 24 Feb 2025, 16:15 |
| BPMC | Blueprint Medicines Corp | 21 Jan 2025 | 4 | -$250,455 | 4 | CHIEF OPERATING OFFICER | 23 Jan 2025, 19:54 |
| BPMC | Blueprint Medicines Corp | 18 Dec 2024 | 2 | -$218,098 | 4 | CHIEF OPERATING OFFICER | 20 Dec 2024, 16:15 |
| BPMC | Blueprint Medicines Corp | 27 Nov 2024 | 1 | -$216,257 | 4 | CHIEF OPERATING OFFICER | 02 Dec 2024, 18:52 |
| BPMC | Blueprint Medicines Corp | 01 Jul 2024 | 1 | $0 | 4 | CHIEF OPERATING OFFICER | 08 Jul 2024, 19:07 |
| XLO | Xilio Therapeutics, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:30 |
| BPMC | Blueprint Medicines Corp | 07 Mar 2024 | 1 | -$550,488 | 4 | CHIEF OPERATING OFFICER | 11 Mar 2024, 18:21 |
| BPMC | Blueprint Medicines Corp | 01 Mar 2024 | 2 | $0 | 4 | CHIEF OPERATING OFFICER | 06 Mar 2024, 16:20 |
| XLO | Xilio Therapeutics, Inc. | 12 Jun 2023 | 1 | $0 | 4 | Director | 13 Jun 2023, 16:30 |
| BPMC | Blueprint Medicines Corp | 06 Mar 2023 | 2 | -$139,715 | 4 | CHIEF OPERATING OFFICER | 08 Mar 2023, 20:36 |
| BPMC | Blueprint Medicines Corp | 01 Mar 2023 | 2 | $0 | 4 | CHIEF OPERATING OFFICER | 03 Mar 2023, 19:07 |
| BPMC | Blueprint Medicines Corp | 03 Nov 2022 | 1 | -$24,113 | 4 | CHIEF OPERATING OFFICER | 07 Nov 2022, 15:08 |
| XLO | Xilio Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:30 |
| BPMC | Blueprint Medicines Corp | 03 Mar 2022 | 2 | -$130,986 | 4 | CHIEF COMMERCIAL OFFICER | 08 Mar 2022, 15:05 |
| BPMC | Blueprint Medicines Corp | 01 Mar 2022 | 2 | $0 | 4 | CHIEF COMMERCIAL OFFICER | 03 Mar 2022, 19:08 |
| BPMC | Blueprint Medicines Corp | 03 Nov 2021 | 1 | -$56,644 | 4 | CHIEF COMMERCIAL OFFICER | 23 Mar 2022, 16:05 |
| XLO | Xilio Therapeutics, Inc. | 21 Oct 2021 | 0 | $0 | 3 | Director | 21 Oct 2021, 20:38 |